For foreign Emerging Stock Board enterprises, ”*- country of incorporation” indicates stocks without par value or with par value other than NT$10, and ”- country of incorporation” indicates stocks with par value of NT$10 per share.
|
Basic information |
Chairman |
President |
Spokesperson |
Telephone |
Address |
ESM Registration Date |
CHIANG,WEI-FENG |
WANG,SHIAN-JY |
WANG,SHIAN-JY |
03-591-0360 |
10F.-1, No. 66, Shengyi 5th Rd., Zhubei City,Hsinchu County 302041, Taiwan (R.O.C.) |
2021/10/19 |
Industrycategory |
Key businesses |
Biotechnology and Medical Care |
MegaPro Biomedical Co., Ltd. (hereinafter referred to as “MegaPro” or the “company”) is a Taiwan located, clinical stage company, which is a spin-off from Industrial Technology Research Institute (ITRI). MegaPro is currently focused on nanomedicine development. The company has two technology platforms, nanoparticles and nanomicelles. The company has two lead products (i) an iron oxide nanoparticle for Iron Deficiency Anemia (IDA), and (ii) as a Magnetic Resonance Imaging (MRI) contrast agent. |
Financial data |
Cash flows statement
| Item
|
|
|
Amount(NTD, in thousands) |
Cash flows from operating activities |
|
|
Cash flows from investing activities |
|
|
Cash flows from financing activities |
|
|
Consolidated/Individual balance sheet
|
Current assets |
|
|
Non-current assets |
|
|
Total assets |
|
|
Current liabilities |
|
|
Non-current liabilities |
|
|
Total liabilities |
|
|
Share capital |
|
|
Capital surplus |
|
|
Retained earnings |
|
|
Other equity interest |
|
|
Treasury shares |
|
|
Total equity attributable to owners of parent |
|
|
Non-controlling interests |
|
|
Total equity |
|
|
Book Value per share(NT$) |
|
|
Consolidated/Individual profit and loss statement |
Operating revenue |
|
|
Operating costs |
|
|
Gross profit from operations |
|
|
Operating expenses |
|
|
Net other income (expenses) |
|
|
Net operating income |
|
|
Non-operating income and expenses |
|
|
Profit before tax |
|
|
Tax expense |
|
|
Profit from continuing operations |
|
|
Profit from discontinued operations |
|
|
Profit |
|
|
Other comprehensive income |
|
|
Comprehensive income |
|
|
Basic earnings per share |
|
|
Auditor's report on latest financial statements: auditor's report:
|
Investors may find more detailed information on the company by visiting the Market Observation Post System.。
|
The information disclosed here concerning foreign enterprises consists of amounts provided in consolidated financial statements.
|